ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

Funding opportunties listed.

December 3, 2004

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000

Drug Development Gets Extra $500,000

November 18, 1977